The Rise of Integrated Financial Platforms
One of the most celebrated sales pitches of all time occurred when then-Apple (AAPL) CEO Steve Jobs first…
Powering the Future of Efficient AI Computing
Arm Holdings plc ARM has emerged as a cornerstone of artificial intelligence innovation, driving efficiency and scalability across…
Can Quantum Computing’s Government Contracts Boost Future Growth?
Quantum Computing Inc. or “QCi” QUBT is continuously focused on strengthening its engagement with strategic government partners. During…
QUBT Gains Commercial Traction With Quantum AI and Cybersecurity Deals (Revised)
During the second quarter of 2025, Quantum Computing Inc. QUBT, or QCi, sold its EmuCore reservoir computing device…
Seeking Quantum Computing Exposure? 2 Stocks Worth a Look
Quantum computing has emerged as a strong investment theme over the past year. with the trend fully expected…
QUBT Gains Commercial Traction With Quantum AI and Cybersecurity Deals
During the second quarter of 2025, Quantum Computing Inc. (QUBT), or QCi, sold its EmuCore reservoir computing device…
Can FUTU’s Wealth Management Take Off?
Futu Holdings Limited FUTU reported a record year-over-year client asset surge of 68.1% and a sequential 17.4% rise…
Quantum Computing Expands Global Reach With New Research Collabs
Quantum Computing Inc. QUBT or QCi continues to gain traction among key academic and research partners worldwide. Recently,…
Dropbox, Crexendo Remain Our Top Picks in Internet Services
Macro factors currently driving the economy, such as inflation, interest rates, labor markets, supply chain issues and so…
Which Quantum Computing Stock Is the Smarter Buy?
Quantum computing is moving from lab prototypes to commercial pathways, and for investors, two pure-play names, Rigetti Computing…
Can Rigetti Computing’s Margin Recover After Second-Quarter Pressure?
Rigetti Computing’s RGTI second-quarter 2025 results gave investors a closer look at the pressures weighing on margins as…
ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression
AbbVie ABBV has announced a deal with private neuroscience biotech, Gilgamesh Pharmaceuticals, to acquire the latter’s lead pipeline…